Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer

Yoshihiko Segawa, Hiroshi Ueoka, Katsuyuki Kiura, Masahiro Tabata, Nagio Takigawa, Yoshio Hiraki, Yoichi Watanabe, Toshiro Yonei, Tomonori Moritaka, Junichiro Hiyama, Shunkichi Hiraki, Mitsune Tanimoto, Mine Harada

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences